DeGroot L J, Rue P A, Nakamura H
J Endocrinol Invest. 1984 Oct;7(5):429-39. doi: 10.1007/BF03348446.
Quantitative and qualitative alterations in protein kinase (PK) activity in preparations of rat liver from hypothyroid (H) and T3-treated hypothyroid animals (T) were analyzed in comparison to enzyme from normal (N) animals. Qualitative variations in type of protein kinase were assessed by chromatography of cytosol preparations on DE-52 cellulose columns. Cytosol kinases resolved into a small fraction I containing a catalytic subunit, fraction II containing a type 1 holoenzyme, fraction III containing a cyclic-AMP independent PK, and fraction IV containing a type 2 holoenzyme. A cytosolic kinase active with casein as substrate was also identified. In H the type 1 holoenzyme was reduced in comparison to N. There were no other qualitative changes. Nuclear PKs were extracted with solvents containing 0.3 M KCl. Qualitative changes were evaluated by chromatography on phosphocellulose columns, but available methodology did not give reproducible evidence of changes in individual PKs. H had significantly more cytosolic PK active with protamine substrate than did normal animals, and by administration of T3, the H level was reduced progressively over 48 h to the N level. The activation ratio of total PK in cytosol was higher in H, and was also reduced to the N level by T3 administration. This suggests a higher steady state level of cyclic-AMP may be present in H rat liver cytosol. Cytosolic protein kinase reactive with casein as substrate increased gradually over 48 h after T3 administration from the H to the higher N level. It was significantly elevated to 110% of the H value by 48 h after T3 administration. The behavior of nuclear PK was entirely different. Nuclear PK reactive with protamine as substrate was increased within 1-1/2 h after T3 administration, reaching a peak of 130% of the control value at 5 h and returning to the normal level by 48 h. In contrast, nuclear PK reactive with casein as substrate also increased by 1-1/2 h after T3 administration and remained elevated at 110-115% of the control value throughout 48 h after T3 administration. The early changes in nuclear PK activity were prevented by administration of cycloheximide or alpha-amanitin. The observed changes in cytosolic PK, including the increment induced by T3 in type 1 enzyme, reduction in
对甲状腺功能减退(H)大鼠肝脏制剂以及经T3处理的甲状腺功能减退动物(T)肝脏制剂中的蛋白激酶(PK)活性进行了定量和定性分析,并与正常(N)动物的酶进行比较。通过在DE - 52纤维素柱上对胞质溶胶制剂进行色谱分析来评估蛋白激酶类型的定性变化。胞质溶胶激酶可分为一小部分I,含有催化亚基;部分II,含有1型全酶;部分III,含有一种不依赖环磷酸腺苷的PK;部分IV,含有2型全酶。还鉴定出一种以酪蛋白为底物具有活性的胞质溶胶激酶。与N相比,H中的1型全酶减少。没有其他定性变化。用含0.3M KCl的溶剂提取核PK。通过在磷酸纤维素柱上进行色谱分析来评估定性变化,但现有方法未给出单个PK变化的可重复证据。与正常动物相比,H中以鱼精蛋白为底物具有活性的胞质溶胶PK明显更多,通过给予T3,H水平在48小时内逐渐降至N水平。H中胞质溶胶中总PK的激活率更高,通过给予T3也降至N水平。这表明H大鼠肝脏胞质溶胶中可能存在较高的环磷酸腺苷稳态水平。以酪蛋白为底物具有反应活性的胞质溶胶蛋白激酶在给予T3后48小时内从H水平逐渐增加到较高的N水平。给予T3后48小时,其显著升高至H值的110%。核PK的行为则完全不同。以鱼精蛋白为底物具有反应活性的核PK在给予T3后1.5小时内增加,在5小时达到对照值的130%峰值,并在给予T3后48小时恢复到正常水平。相比之下,以酪蛋白为底物具有反应活性的核PK在给予T3后1.5小时也增加,并在给予T3后48小时内一直保持在对照值的110 - 115%升高水平。核PK活性的早期变化可通过给予放线菌酮或α - 鹅膏蕈碱来预防。观察到的胞质溶胶PK变化,包括T3诱导的1型酶增加、降低……